Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

KPRXKIORA PHARMACEUTICALS INC

Nasdaq · CIK 0001372514
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts435

Identity from submissions API

NameKIORA PHARMACEUTICALS INC
CIK0001372514
TickersKPRX, KPHMW
ExchangesNasdaq, OTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN980443284
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone858-224-9600
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • EYEGATE PHARMACEUTICALS INC (2006-08-09T04:00:00.000Z → 2021-11-04T04:00:00.000Z)
Business address
169 SAXONY RD.
SUITE 212
ENCINITAS
CA
92024
CA
Mailing address
169 SAXONY RD.
SUITE 212
ENCINITAS
CA
92024
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

929 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005391 005-88748 261561999 34 11497
2026-11-12 8-K 8-K 2.02,9.01 0001372514-26-000093 001-36672 261543078 34 1121641 1 1
2026-11-12 10-Q 10-Q 0001372514-26-000092 001-36672 261543064 34 9080371 1 1
2026-10-29 8-K 8-K 1.01,7.01,9.01 0001372514-26-000088 001-36672 261497414 34 4199483 1 1
2026-09-17 4 FORM 4 0001372514-26-000085 5834
2026-09-17 3 FORM 3 0001372514-26-000083 506249
2026-09-17 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001957912-26-000030 005-88748 261386898 34 17819
2026-09-08 8-K 8-K 5.02,7.01,9.01 0001372514-26-000079 001-36672 261363353 34 257334 1 1
2026-08-19 8-K 8-K 1.01,7.01,9.01 0001372514-26-000077 001-36672 261292872 34 677317 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097323 005-88748 261283339 34 14308
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097279 005-88748 261282915 34 11536
2026-08-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-341731 005-88748 261257280 34 12524
2026-08-07 8-K 8-K 2.02,9.01 0001372514-26-000075 001-36672 261251375 34 1108322 1 1
2026-08-07 10-Q 10-Q 0001372514-26-000074 001-36672 261251370 34 8655118 1 1
2026-07-02 4 FORM 4 0001372514-26-000067 4849
2026-07-02 4 FORM 4 0001372514-26-000065 4887
2026-06-18 8-K 8-K 7.01,9.01 0001372514-26-000063 001-36672 261100391 34 999298 1 1
2026-06-12 4 FORM 4 0001861519-26-000002 5638
2026-06-12 4 FORM 4 0001855207-26-000002 5648
2026-06-12 4 FORM 4 0001895795-26-000001 5590
2026-06-12 4 FORM 4 0001793796-26-000002 5652
2026-06-12 4 FORM 4 0001711576-26-000002 5665
2026-06-12 4 FORM 4 0001372514-26-000061 5598
2026-06-11 8-K 8-K 5.02,5.07,9.01 0001372514-26-000059 001-36672 261080985 34 310672 1 1
2026-05-28 424B3 424B3 0001372514-26-000057 333-295994 261038022 33 631503
2026-05-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001753 333-295994 261015774 33 1854
2026-05-20 CORRESP filename1.htm 0001372514-26-000053 493527
2026-05-20 UPLOAD filename1.pdf 0000000000-26-005167 333-295994 147405
2026-05-18 S-3 S-3 0001372514-26-000050 333-295994 26994043 33 578013 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062696 005-88748 26988936 34 11537
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002365 005-88748 26988747 34 11299
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062628 005-88748 26988418 34 7877
2026-05-08 8-K 8-K 2.02,9.01 0001372514-26-000048 001-36672 26956021 34 1084443 1 1
2026-05-08 10-Q 10-Q 0001372514-26-000047 001-36672 26956019 34 7874235 1 1
2026-05-01 ARS ARS - 10-K 0001372514-26-000043 001-36672 26932316 34 7983621
2026-04-30 DEF 14A DEF 14A 0001372514-26-000040 001-36672 26927140 34 3032545 1 1
2026-04-21 D xslFormDX01/primary_doc.xml 06b 0001372514-26-000038 021-581327 26880185 33 11814
2026-04-07 8-K 8-K 1.01,3.02,7.01,9.01 0001372514-26-000036 001-36672 26842888 34 1555415 1 1
2026-04-02 4 FORM 4 0001372514-26-000034 4817
2026-04-02 4 FORM 4 0001372514-26-000032 4872
2026-04-02 4 FORM 4 0001372514-26-000030 4855
2026-04-02 8-K 8-K 5.02,7.01,9.01 0001372514-26-000028 001-36672 26834662 34 993893 1 1
2026-03-25 S-8 S-8 0001372514-26-000026 333-294582 26788383 33 805103 1 1
2026-03-25 8-K 8-K 2.02,9.01 0001372514-26-000025 001-36672 26788349 34 1096593 1 1
2026-03-25 10-K 10-K 0001372514-26-000024 001-36672 26788348 34 11978126 1 1
2026-03-10 4 FORM 4 0001372514-26-000014 7552
2026-03-10 4 FORM 4 0001372514-26-000013 7535
2026-03-10 4 FORM 4 0001372514-26-000012 7500
2026-03-06 4 FORM 4 0001372514-26-000007 4702
2026-03-06 4 FORM 4 0001372514-26-000006 4717
2026-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001622627-26-000010 005-88748 26619889 34 15384
2026-01-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-004296 005-88748 26580075 34 9834
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112617 005-88748 251487159 34 11972
2025-11-07 8-K 8-K 2.02,9.01 0001372514-25-000079 001-36672 251460258 34 1111901 1 1
2025-11-07 10-Q 10-Q 0001372514-25-000078 001-36672 251460250 34 8615324 1 1
2025-09-19 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003030 333-290263 251328304 33 1823
2025-09-17 CORRESP filename1.htm 0001372514-25-000074 8530
2025-09-16 UPLOAD filename1.pdf 0000000000-25-010034 333-290263 40184
2025-09-15 S-3 S-3 0001372514-25-000072 333-290263 251314510 33 2926577 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078840 005-88748 251221948 34 13833
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-078696 005-88748 251220150 34 8161
2025-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001579206-25-000012 005-88748 251210482 34 15263
2025-08-13 8-K 8-K 7.01 0001372514-25-000068 001-36672 251208295 34 3799532 1 1
2025-08-08 8-K 8-K 2.02,9.01 0001372514-25-000064 001-36672 251196187 34 1114014 1 1
2025-08-08 10-Q 10-Q 0001372514-25-000061 001-36672 251196164 34 16608912 1 1
2025-07-01 UPLOAD filename1.pdf 0000000000-25-006943 001-36672 39723
2025-06-20 CORRESP filename1.htm 0001372514-25-000057 1688271
2025-06-10 UPLOAD filename1.pdf 0000000000-25-006099 001-36672 44956
2025-06-04 8-K 8-K 5.07,9.01 0001372514-25-000053 001-36672 251022773 34 158883 1 1
2025-06-03 8-K 8-K 1.01,7.01,9.01 0001372514-25-000050 001-36672 251017134 34 325353 1 1
2025-05-09 8-K 8-K 2.02,9.01 0001372514-25-000045 001-36672 25928324 34 1090489 1 1
2025-05-09 10-Q 10-Q 0001372514-25-000044 001-36672 25928305 34 7473176 1 1
2025-04-30 DEF 14A DEF 14A 0001372514-25-000038 001-36672 25891620 34 3898695 1 1
2025-04-02 4 FORM 4 0001372514-25-000036 7562
2025-04-02 4 FORM 4 0001372514-25-000035 7606
2025-04-02 4 FORM 4 0001372514-25-000034 7589
2025-04-02 4 FORM 4 0001372514-25-000030 5533
2025-04-02 4 FORM 4 0001372514-25-000029 5475
2025-04-02 4 FORM 4 0001372514-25-000028 5537
2025-04-02 4 FORM 4 0001372514-25-000027 5483
2025-04-02 4 FORM 4 0001372514-25-000026 5523
2025-04-02 4 FORM 4 0001372514-25-000025 5550
2025-03-25 8-K 8-K 2.02,9.01 0001372514-25-000014 001-36672 25765798 34 259709 1 1
2025-03-25 S-8 S-8 0001372514-25-000013 333-286073 25765788 33 205816
2025-03-25 10-K 10-K 0001372514-25-000012 001-36672 25765785 34 9994714 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001174 005-88748 25629431 34 10853
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000769993-25-000128 005-88748 25613337 34 16798
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001622627-25-000006 005-88748 25605702 34 15767
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-005552 005-88748 25603826 34 9691
2025-01-15 8-K 8-K 5.02,9.01 0001372514-25-000003 001-36672 25533748 34 332951 1 1
2024-11-14 SC 13G/A sch13g.htm 0000929638-24-003919 005-88748 241465178 34 75408
2024-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-119156 005-88748 241463834 34 11328
2024-11-14 SC 13G SC 13G 0001104659-24-119078 005-88748 241463643 34 92830
2024-11-14 SC 13G alyeska-kprx093024.htm 0001172661-24-005256 005-88748 241463262 34 106491
2024-11-13 SC 13G/A kprx13ga1.htm 0000935836-24-000668 005-88748 241455860 34 61465
2024-11-12 SC 13G KIORA.txt 0000769993-24-000422 005-88748 241450317 34 23848
2024-11-08 8-K 8-K 2.02,9.01 0001372514-24-000121 001-36672 241437964 34 280412 1 1
2024-11-08 10-Q 10-Q 0001372514-24-000120 001-36672 241437953 34 6875287 1 1
2024-10-29 8-K 8-K 7.01,9.01 0001372514-24-000117 001-36672 241402643 34 4767161 1 1
2024-09-12 4 FORM 4 0001372514-24-000115 5186
2024-09-11 4 FORM 4 0001372514-24-000113 4876
2024-08-20 4 FORM 4 0001372514-24-000111 5228
2024-08-19 4 FORM 4 0001372514-24-000109 4678
2024-08-15 4 FORM 4 0001372514-24-000107 5246
2024-08-09 8-K 8-K 2.02,9.01 0001372514-24-000105 001-36672 241190372 34 279077 1 1
2024-08-09 10-Q 10-Q 0001372514-24-000104 001-36672 241190366 34 6745495 1 1
2024-07-30 8-K 8-K 8.01,9.01 0001372514-24-000099 001-36672 241154353 34 169349 1 1
2024-07-03 4 FORM 4 0001372514-24-000097 7593
2024-07-03 4 FORM 4 0001372514-24-000096 7584
2024-07-03 3 FORM 3 0001372514-24-000095 533625
2024-07-03 4 FORM 4 0001372514-24-000094 7610
2024-07-03 4 FORM 4 0001372514-24-000093 5515
2024-07-03 4 FORM 4 0001372514-24-000092 5479
2024-07-03 4 FORM 4 0001372514-24-000091 5537
2024-07-03 4 FORM 4 0001372514-24-000090 5554
2024-07-03 4 FORM 4 0001372514-24-000089 5541
2024-07-03 4 FORM 4 0001372514-24-000088 5487
2024-07-01 8-K 8-K 5.02,7.01,8.01,9.01 0001372514-24-000068 001-36672 241088149 34 202227 1 1
2024-06-14 4 FORM 4 0001372514-24-000065 4790
2024-06-14 4 FORM 4 0001372514-24-000063 4810
2024-06-13 4 FORM 4 0001372514-24-000061 4788
2024-06-13 4 FORM 4 0001372514-24-000060 4793
2024-06-07 8-K 8-K 3.03,5.03,8.01,9.01 0001372514-24-000057 001-36672 241027259 34 176137 1 1
2024-05-29 SC 13G rosalind_kprx_13g_feb202.htm 0001622627-24-000035 005-88748 24998094 34 94832
2024-05-29 SC 13G rosalind_kprx_13g_feb202.htm 0001622627-24-000037 005-88748 24998030 34 94832
2024-05-10 8-K 8-K 2.02,9.01 0001372514-24-000054 001-36672 24932839 34 364590 1 1
2024-05-10 10-Q 10-Q 0001372514-24-000053 001-36672 24932830 34 5172076 1 1
2024-05-10 S-8 S-8 0001372514-24-000052 333-279296 24932824 33 142053
2024-05-03 8-K 8-K 5.03,5.07,9.01 0001372514-24-000039 001-36672 24910086 34 211002 1 1
2024-03-28 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-03-28 16:30:00 9999999995-24-000765 333-277460 24801838 33 1878
2024-03-28 424B3 424B3 0001372514-24-000035 333-277460 24799936 33 259562
2024-03-26 CORRESP filename1.htm 0001372514-24-000032 199248
2024-03-25 DEF 14A DEF 14A 0001372514-24-000030 001-36672 24779683 34 1494876
2024-03-25 8-K 8-K 2.02,9.01 0001372514-24-000027 001-36672 24776863 34 255626 1 1
2024-03-25 10-K 10-K 0001372514-24-000026 001-36672 24776862 34 8216585 1 1
2024-03-15 PRE 14A PRE 14A 0001372514-24-000023 001-36672 24752438 34 1510565
2024-03-04 UPLOAD filename1.pdf 0000000000-24-002419 333-277460 40816
2024-02-28 S-3 S-3 0001372514-24-000020 333-277460 24696220 33 458056
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023915 005-88748 24639920 34 145307
2024-02-14 D xslFormDX01/primary_doc.xml 06b 0001372514-24-000014 021-505316 24637178 33 13634
2024-02-13 SC 13G/A sch13g.htm 0000929638-24-000569 005-88748 24631305 34 75813
2024-02-12 8-K 8-K 7.01,9.01 0001372514-24-000013 001-36672 24621373 34 4998254 1 1
2024-02-09 SC 13G kiora13g.htm 0000935836-24-000122 005-88748 24615163 34 60334
2024-02-07 SC 13G formsc13g.htm 0001493152-24-005214 005-88748 24602418 34 90156
2024-02-06 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-24-010336 005-88748 24598691 34 73436
2024-02-01 8-K 8-K 1.01,3.02,7.01,9.01 0001372514-24-000010 001-36672 24585009 34 38951145 1 1
2024-01-31 8-K 8-K 1.01,7.01,9.01 0001372514-24-000007 001-36672 24583917 34 13538390 1 1
2024-01-16 8-K 8-K 3.01 0001372514-24-000002 001-36672 24535997 34 156520 1 1
2023-11-09 8-K 8-K 7.01,9.01 0001372514-23-000160 001-36672 231389988 34 4370281 1 1
2023-11-09 8-K 8-K 2.02,9.01 0001372514-23-000159 001-36672 231389987 34 180840 1 1
2023-11-09 10-Q 10-Q 0001372514-23-000158 001-36672 231389980 34 6340274 1 1
2023-11-06 8-K 8-K 9.01 0001372514-23-000154 001-36672 231377986 34 183353 1 1
2023-10-13 S-8 S-8 0001372514-23-000152 333-274974 231325653 33 129207
2023-10-03 4 FORM 4 0001372514-23-000150 7652
2023-10-03 4 FORM 4 0001372514-23-000149 7691
2023-10-03 4 FORM 4 0001372514-23-000148 7674
2023-10-03 4 FORM 4 0001372514-23-000147 5371
2023-10-03 4 FORM 4 0001372514-23-000146 5421
2023-10-03 4 FORM 4 0001372514-23-000145 5399
2023-10-03 4 FORM 4 0001372514-23-000144 5422
2023-10-03 4 FORM 4 0001372514-23-000143 5373
2023-10-03 4 FORM 4 0001372514-23-000142 5363
2023-09-28 8-K 8-K 5.07 0001372514-23-000132 001-36672 231285809 34 165032 1 1
2023-09-21 8-K 8-K 5.02,8.01,9.01 0001372514-23-000129 001-36672 231267715 34 168779 1 1
2023-09-01 DEFA14A DEFA14A 0001372514-23-000126 001-36672 231230580 34 32853
2023-09-01 8-K 8-K 8.01,9.01 0001372514-23-000125 001-36672 231230571 34 172603 1 1
2023-08-10 3 FORM 3 0001372514-23-000120 578842
2023-08-08 8-K 8-K 2.02,9.01 0001372514-23-000118 001-36672 231149294 34 187628 1 1
2023-08-08 10-Q 10-Q 0001372514-23-000117 001-36672 231149292 34 5372195 1 1
2023-08-01 8-K 8-K 5.02,7.01,9.01 0001372514-23-000112 001-36672 231129592 34 176239 1 1
2023-07-21 DEF 14A DEF 14A 0001372514-23-000110 001-36672 231103012 34 1035967
2023-07-20 8-K 8-K 3.01 0001372514-23-000107 001-36672 231100401 34 156354 1 1
2023-07-11 PRE 14A PRE 14A 0001372514-23-000105 001-36672 231082667 34 1037422
2023-06-21 8-K 8-K 5.07 0001372514-23-000103 001-36672 231030199 34 171191 1 1
2023-06-15 8-K 8-K 1.01,8.01,9.01 0001372514-23-000101 001-36672 231018199 34 399603 1 1
2023-06-13 SC 13G sc13g.htm 0000929638-23-001718 005-88748 231011253 34 81903
2023-06-06 8-K 8-K 1.01,5.03,8.01,9.01 0001372514-23-000097 001-36672 23996737 34 913900 1 1
2023-06-02 424B1 424B1 0001372514-23-000090 333-271699 23990039 33 2380053
2023-06-01 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-06-01 16:30:00 9999999995-23-001605 333-271699 23986631 33 1829
2023-06-01 S-1/A S-1/A 0001372514-23-000085 333-271699 23982423 33 3338904
2023-05-31 CORRESP filename1.htm 0001372514-23-000088 142217
2023-05-31 CORRESP filename1.htm 0001372514-23-000086 333639
2023-05-24 CORRESP filename1.htm 0001372514-23-000080 164296
2023-05-24 CORRESP filename1.htm 0001372514-23-000078 142646
2023-05-23 CORRESP filename1.htm 0001372514-23-000076 199771
2023-05-15 FWP FWP 0001372514-23-000073 333-271699 23924362 34 4873803
2023-05-12 S-1/A S-1/A 0001628280-23-017953 333-271699 23916874 33 3260526
2023-05-09 UPLOAD filename1.pdf 0000000000-23-004849 40399
2023-05-09 8-K 8-K 2.02,9.01 0001372514-23-000070 001-36672 23899900 34 197647 1 1
2023-05-09 10-Q 10-Q 0001372514-23-000069 001-36672 23899867 34 4781734 1 1
2023-05-05 S-1 S-1 0001628280-23-016198 333-271699 23894817 33 2577191
2023-04-28 DEF 14A DEF 14A 0001372514-23-000059 001-36672 23863965 34 2527350
2023-04-27 8-K 8-K 8.01,9.01 0001372514-23-000057 001-36672 23855761 34 497021 1 1
2023-03-30 8-K 8-K 4.01,9.01 0001372514-23-000053 001-36672 23777125 34 167768 1 1
2023-03-23 8-K 8-K 2.02,9.01 0001372514-23-000051 001-36672 23754427 34 783011 1 1
2023-03-23 10-K 10-K 0001372514-23-000050 001-36672 23754426 34 13144138 1 1
2023-03-07 4 FORM 4 0001372514-23-000037 5380
2023-03-07 4 FORM 4 0001372514-23-000036 7429
2023-03-07 4 FORM 4 0001372514-23-000035 7458
2023-03-07 4 FORM 4 0001372514-23-000034 7473
2023-03-07 4 FORM 4 0001372514-23-000033 5390
2023-03-07 4 FORM 4 0001372514-23-000032 5438
2023-03-07 4 FORM 4 0001372514-23-000031 5388
2023-03-07 4 FORM 4 0001372514-23-000030 5442
2023-03-07 4 FORM 4 0001372514-23-000029 5392
2023-02-17 D xslFormDX01/primary_doc.xml 06b 0001104659-23-023307 021-473810 23643172 33 12375
2023-02-17 D xslFormDX01/primary_doc.xml 06b 0001104659-23-023304 021-473809 23643140 33 12244
2023-02-14 SC 13G/A armistice-kprx123122a1.htm 0001172661-23-001125 005-88748 23626062 34 90704
2023-02-13 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-02-13 16:30:00 9999999995-23-000410 333-269570 23621670 33 1829
2023-02-13 424B3 424B3 0001104659-23-019770 333-269570 23619337 33 310812
2023-02-13 SC 13G/A AMENDMENT NO. 1 0000929638-23-000424 005-88748 23619173 34 83404
2023-02-13 SC 13G (AMENDMENT NO. 1)* 0000929638-23-000423 005-88748 23619153 34 81754
2023-02-09 CORRESP filename1.htm 0001104659-23-017632 9736
2023-02-09 UPLOAD filename1.pdf 0000000000-23-001364 40283
2023-02-08 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-23-009118 005-88748 23596951 34 67241
2023-02-07 8-K 8-K 8.01,9.01 0001372514-23-000010 001-36672 23592746 34 188331 1 1
2023-02-03 S-1 S-1 0001104659-23-010675 333-269570 23587403 33 476736
2023-02-03 8-K 8-K 1.01,3.02,8.01,9.01 0001372514-23-000008 001-36672 23583709 34 1277426 1 1
2023-01-09 8-K FORM 8-K 7.01,9.01 0001104659-23-002295 001-36672 23518494 34 17063310 1 1
2023-01-03 8-K FORM 8-K 8.01 0001104659-23-000363 001-36672 23502562 34 239357 1 1
2022-12-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-12-28 16:30:00 9999999995-22-003657 333-268940 221496254 33 1836
2022-12-28 424B3 424B3 0001104659-22-130560 333-268940 221495187 33 1072607
2022-12-23 CORRESP filename1.htm 0001104659-22-129907 7668
2022-12-23 UPLOAD filename1.pdf 0000000000-22-013880 40355
2022-12-22 S-1 S-1 0001104659-22-129237 333-268940 221479503 33 1229574
2022-11-21 424B3 424B3 0001104659-22-120487 333-264641 221403463 33 47945
2022-11-21 8-K FORM 8-K 1.01,3.02,3.03,8.01,9.01 0001104659-22-120486 001-36672 221403460 34 441000 1 1
2022-11-09 10-Q 10-Q 0001410578-22-003035 001-36672 221370526 34 6698892 1 1
2022-10-25 4 OWNERSHIP DOCUMENT 0001104659-22-111246 7733
2022-10-25 4 OWNERSHIP DOCUMENT 0001104659-22-111243 7703
2022-10-25 4 OWNERSHIP DOCUMENT 0001104659-22-111239 7715
2022-10-13 8-K FORM 8-K 8.01,9.01 0001104659-22-108263 001-36672 221308047 34 207223 1 1
2022-10-05 S-8 FORM S-8 0001104659-22-106341 333-267754 221296139 33 67179
2022-09-26 8-K FORM 8-K 3.03,5.03,8.01,9.01 0001104659-22-102816 001-36672 221263571 34 229916 1 1
2022-09-23 8-K FORM 8-K 5.07 0001104659-22-102697 001-36672 221262672 34 215461 1 1
2022-09-22 3 OWNERSHIP DOCUMENT 0001104659-22-102352 13374
2022-09-16 8-K FORM 8-K 5.02,5.07,8.01,9.01 0001104659-22-100852 001-36672 221248435 34 245500 1 1
2022-08-25 8-K FORM 8-K 3.01 0001104659-22-094445 001-36672 221197910 34 197786 1 1
2022-08-15 DEF 14A DEF 14A 0001104659-22-091303 001-36672 221167270 34 3516982
2022-08-12 10-Q 10-Q 0001410578-22-002336 001-36672 221157716 34 5765287 1 1
2022-08-08 DEF 14A DEF 14A 0001104659-22-087273 001-36672 221144840 34 1440988
2022-08-05 SC 13G sc13g.htm 0000929638-22-001277 005-88748 221141801 34 83321
2022-08-05 PRE 14A PRE 14A 0001104659-22-086740 001-36672 221141663 34 3509489
2022-08-04 8-K FORM 8-K 5.03,9.01 0001104659-22-086182 001-36672 221137249 34 323593 1 1
2022-08-01 SC 13G SCHEDULE 13G 0001213900-22-043137 005-88748 221122667 34 71761
2022-07-28 SC 13G SC 13G 0001104659-22-083721 005-88748 221116162 34 136112
2022-07-27 PRE 14A PRE 14A 0001104659-22-083236 001-36672 221111835 34 4772191
2022-07-26 8-K FORM 8-K 1.01,5.03,8.01,9.01 0001104659-22-082802 001-36672 221107458 34 833710 1 1
2022-07-25 424B1 424B1 0001104659-22-082104 333-264641 221100708 33 2168259
2022-07-21 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-07-21 17:30:00 9999999995-22-002123 333-264641 221098361 33 1836
2022-07-21 CORRESP filename1.htm 0001104659-22-081568 7338
2022-07-21 S-1/A S-1/A 0001104659-22-081271 333-264641 221095350 33 2964959
2022-07-19 CORRESP filename1.htm 0001104659-22-080882 8314
2022-07-19 S-1/A S-1/A 0001104659-22-080880 333-264641 221092195 33 2839281
2022-07-14 FWP FREE WRITING PROSPECTUS 0001104659-22-079906 333-264641 221083602 34 2718983
2022-07-13 S-1/A S-1/A 0001104659-22-079591 333-264641 221081668 33 2971862
2022-07-08 10-Q 10-Q 0001410578-22-001934 001-36672 221075151 34 4747121 1 1
2022-07-07 10-K/A 10-K/A 0001410578-22-001931 001-36672 221069851 34 20067087 1 1
2022-06-21 8-K FORM 8-K 5.02 0001104659-22-073063 001-36672 221029095 34 196125 1 1
2022-05-31 8-K FORM 8-K 3.01,7.01,9.01 0001104659-22-066571 001-36672 22983731 34 216385 1 1
2022-05-23 8-K FORM 8-K 4.02,9.01 0001104659-22-063871 001-36672 22952107 34 207969 1 1
2022-05-17 NT 10-Q NT 10-Q 0001104659-22-061687 001-36672 22932200 34 26451
2022-05-09 UPLOAD filename1.pdf 0000000000-22-005074 40336
2022-05-03 S-1 S-1 0001104659-22-055297 333-264641 22887641 33 2099605
2022-05-03 S-8 FORM S-8 0001104659-22-055295 333-264640 22887591 33 64373
2022-05-02 3 OWNERSHIP DOCUMENT 0001104659-22-054848 13265
2022-04-26 8-K FORM 8-K 5.02,9.01 0001104659-22-049935 001-36672 22851707 34 297467 1 1
2022-04-15 10-K 10-K 0001410578-22-000925 001-36672 22829125 34 8879608 1 1
2022-03-31 NT 10-K FORM NT 10-K 0001104659-22-041081 001-36672 22793082 34 24578
2022-03-23 8-K 8-K 5.02 0001104659-22-037086 001-36672 22763778 34 195817 1 1
2022-02-28 8-K FORM 8-K 3.01,5.02 0001104659-22-028121 001-36672 22690196 34 200758 1 1
2022-02-15 SC 13G/A SC 13G/A 0001193125-22-042355 005-88748 22635724 34 64917
2022-02-14 8-K FORM 8-K 5.02 0001104659-22-023200 001-36672 22634944 34 195353 1 1
2022-02-11 SC 13G/A sc13g.htm 0000929638-22-000426 005-88748 22622547 34 69250
2022-02-11 4 OWNERSHIP DOCUMENT 0001104659-22-020560 5330
2022-02-03 4 OWNERSHIP DOCUMENT 0001104659-22-011498 5645
2022-02-03 4 OWNERSHIP DOCUMENT 0001104659-22-011497 5471
2022-02-03 4 OWNERSHIP DOCUMENT 0001104659-22-011496 5475
2022-02-03 4 OWNERSHIP DOCUMENT 0001104659-22-011495 5473
2022-02-03 4 OWNERSHIP DOCUMENT 0001104659-22-011494 8076
2022-02-03 4 OWNERSHIP DOCUMENT 0001104659-22-011493 5733
2022-02-03 4 OWNERSHIP DOCUMENT 0001104659-22-011492 8138
2022-02-03 4 OWNERSHIP DOCUMENT 0001104659-22-011491 5715
2022-02-03 4 OWNERSHIP DOCUMENT 0001104659-22-011490 5521
2022-02-03 3 OWNERSHIP DOCUMENT 0001104659-22-011385 12703
2022-02-01 8-K FORM 8-K 5.02,7.01,9.01 0001104659-22-010000 001-36672 22576838 34 326860 1 1
2022-01-27 SC 13G/A sc13ga110022002kio_01272022.htm 0000921895-22-000252 005-88748 22563795 34 211993
2022-01-24 SC 13G/A KIORA PHARMACEUTICALS, INC. 0000902664-22-000497 005-88748 22547844 34 80231
2022-01-11 8-K FORM 8-K 7.01,9.01 0001104659-22-002825 001-36672 22522240 34 4116762 1 1
2022-01-06 4 OWNERSHIP DOCUMENT 0001104659-22-001943 4753
2022-01-06 4 OWNERSHIP DOCUMENT 0001104659-22-001942 4800
2021-12-23 3 OWNERSHIP DOCUMENT 0001104659-21-153153 12934
2021-12-15 8-K FORM 8-K 5.02,7.01,9.01 0001104659-21-149776 001-36672 211493071 34 232745 1 1
2021-12-14 8-K FORM 8-K 8.01,9.01 0001104659-21-149386 001-36672 211489660 34 229510 1 1
2021-12-08 4 OWNERSHIP DOCUMENT 0001104659-21-147638 4802
2021-12-08 4 OWNERSHIP DOCUMENT 0001104659-21-147635 4754
2021-11-22 4 OWNERSHIP DOCUMENT 0001104659-21-142537 6951
2021-11-22 4/A FORM 4/A 0001104659-21-142530 5134
2021-11-15 10-Q 10-Q 0001410578-21-000215 001-36672 211406335 34 6216241 1 1
2021-11-10 4 OWNERSHIP DOCUMENT 0001104659-21-136953 5739
2021-11-10 3 OWNERSHIP DOCUMENT 0001104659-21-136951 13256
2021-11-08 8-K FORM 8-K 5.03,8.01,9.01 0001104659-21-135333 001-36672 211386528 34 430135 1 1
2021-11-04 D xslFormDX01/primary_doc.xml 06b 0001104659-21-134407 021-419911 211380302 33 11616
2021-11-03 4 OWNERSHIP DOCUMENT 0001104659-21-133655 4696
2021-11-03 4 OWNERSHIP DOCUMENT 0001104659-21-133652 4731
2021-11-03 4 OWNERSHIP DOCUMENT 0001104659-21-133650 4648
2021-10-26 8-K FORM 8-K 1.01,2.01,3.02,5.02,7.01,9.01 0001104659-21-129738 001-36672 211345899 34 677414 1 1
2021-10-05 4 OWNERSHIP DOCUMENT 0001104659-21-123267 4648
2021-10-05 4 OWNERSHIP DOCUMENT 0001104659-21-123266 4732
2021-10-05 4 OWNERSHIP DOCUMENT 0001104659-21-123265 4696
2021-09-14 8-K FORM 8-K 7.01,9.01 0001104659-21-115504 001-36672 211252608 34 7211449 1 1
2021-09-03 4 OWNERSHIP DOCUMENT 0001104659-21-112942 5276
2021-09-03 4 OWNERSHIP DOCUMENT 0001104659-21-112940 5229
2021-09-03 4 OWNERSHIP DOCUMENT 0001104659-21-112937 4731
2021-08-26 8-K FORM 8-K 5.02 0001104659-21-109807 001-36672 211212543 34 192312 1 1
2021-08-23 D xslFormDX01/primary_doc.xml 06b 0001104659-21-108575 021-410958 211197016 33 12470
2021-08-20 SC 13G sc13g.htm 0000929638-21-001028 005-88748 211194370 34 63660
2021-08-20 SC 13G EYEGATE PHARMACEUTICALS, INC. 0000902664-21-003980 005-88748 211194332 34 85826
2021-08-19 SC 13G sc13g10022001_08192021.htm 0000921895-21-002155 005-88748 211190437 34 227172
2021-08-18 SC 13G SCHEDULE 13G 0001213900-21-043647 005-88748 211186865 34 142647
2021-08-17 SC 13G sc13g.htm 0000929638-21-001017 005-88748 211183365 34 63763
2021-08-13 SC 13G form_sc13g-eyegate.htm 0001011438-21-000197 005-88748 211171982 34 117289
2021-08-12 10-Q FORM 10-Q 0001104659-21-104182 001-36672 211167848 34 6026327 1 1
2021-08-11 424B5 424B5 0001104659-21-103162 333-231204 211161915 33 448744
2021-08-10 8-K FOMR 8-K 1.01,3.02,8.01,9.01 0001104659-21-102512 001-36672 211158382 34 603877
2021-08-04 4 OWNERSHIP DOCUMENT 0001104659-21-100200 4696
2021-08-04 4 OWNERSHIP DOCUMENT 0001104659-21-100199 4702
2021-08-04 4 OWNERSHIP DOCUMENT 0001104659-21-100197 4732
2021-08-04 4 OWNERSHIP DOCUMENT 0001104659-21-100196 4648
2021-08-04 8-K FORM 8-K 5.02 0001104659-21-099777 001-36672 211142278 34 17012
2021-08-03 4 FORM 4 0001567619-21-014361 16888
2021-08-03 SC 13D/A form_sc13da-eyegate.htm 0001011438-21-000187 005-88748 211140818 34 92796
2021-08-02 4 OWNERSHIP DOCUMENT 0001104659-21-098991 5604
2021-08-02 3 OWNERSHIP DOCUMENT 0001104659-21-098978 13160
2021-07-29 4 FORM 4 SUBMISSION 0000899243-21-030722 26440
2021-07-26 8-K FORM 8-K 5.02,7.01,9.01 0001104659-21-095852 001-36672 211114362 34 121804
2021-07-06 4 OWNERSHIP DOCUMENT 0001104659-21-089447 4645
2021-07-06 4 OWNERSHIP DOCUMENT 0001104659-21-089446 5366
2021-07-06 4 OWNERSHIP DOCUMENT 0001104659-21-089443 4814
2021-07-06 4 OWNERSHIP DOCUMENT 0001104659-21-089442 5359
2021-06-25 8-K 8-K 5.07 0001104659-21-085746 001-36672 211048319 34 33838
2021-06-07 4 OWNERSHIP DOCUMENT 0001104659-21-077766 5277
2021-06-07 4 OWNERSHIP DOCUMENT 0001104659-21-077765 5230
2021-06-07 4 OWNERSHIP DOCUMENT 0001104659-21-077764 5284
2021-06-07 4 OWNERSHIP DOCUMENT 0001104659-21-077763 5314
2021-05-27 8-K FORM 8-K 7.01,9.01 0001104659-21-072696 001-36672 21968497 34 4050787
2021-05-12 10-Q FORM 10-Q 0001104659-21-065128 001-36672 21915297 34 4359889 1
2021-05-05 4 OWNERSHIP DOCUMENT 0001104659-21-061950 5272
2021-05-05 4 OWNERSHIP DOCUMENT 0001104659-21-061949 5225
2021-05-05 4 OWNERSHIP DOCUMENT 0001104659-21-061948 5279
2021-05-05 4 OWNERSHIP DOCUMENT 0001104659-21-061946 5309
2021-04-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-04-30 16:30:00 9999999995-21-001694 333-255311 21881072 33 1723
2021-04-30 424B3 424B3 0001104659-21-059157 333-255311 21879319 33 272579
2021-04-30 DEFA14A DEFA14A 0001104659-21-059003 001-36672 21877931 34 736020
2021-04-30 DEF 14A DEF 14A 0001104659-21-058990 001-36672 21877829 34 3154881
2021-04-28 CORRESP filename1.htm 0001104659-21-056603 6626
2021-04-21 4 FORM 4 0001104659-21-053167 5521
2021-04-21 4 FORM 4 0001104659-21-053166 5569
2021-04-21 UPLOAD filename1.pdf 0000000000-21-004928 40215
2021-04-20 PRE 14A PRE 14A 0001104659-21-052534 001-36672 21838031 34 1230014
2021-04-16 S-3 FORM S-3 0001104659-21-051434 333-255311 21832128 33 385406
2021-04-14 3 OWNERSHIP DOCUMENT 0001104659-21-050215 13351
2021-04-12 3 OWNERSHIP DOCUMENT 0001104659-21-049419 13051
2021-04-09 4 OWNERSHIP DOCUMENT 0001104659-21-048716 5276
2021-04-09 4 OWNERSHIP DOCUMENT 0001104659-21-048715 5229
2021-04-09 4 OWNERSHIP DOCUMENT 0001104659-21-048714 5283
2021-04-09 4 OWNERSHIP DOCUMENT 0001104659-21-048712 4732
2021-04-01 8-K FORM 8-K 5.02,7.01,9.01 0001104659-21-045169 001-36672 21795987 34 32795
2021-03-25 10-K FORM 10-K 0001104659-21-041515 001-36672 21772563 34 6991909 1
2021-03-05 4 OWNERSHIP DOCUMENT 0001104659-21-032768 5271
2021-03-05 4 OWNERSHIP DOCUMENT 0001104659-21-032766 5224
2021-03-05 4 OWNERSHIP DOCUMENT 0001104659-21-032764 5278
2021-03-05 4 OWNERSHIP DOCUMENT 0001104659-21-032763 5307
2021-03-05 8-K/A FORM 8-K/A 9.01 0001104659-21-032744 001-36672 21718669 34 1151925
2021-02-09 SC 13G/A EYEG 13GA 0001393825-21-000031 005-88748 21605809 34 54225
2021-02-03 4 OWNERSHIP DOCUMENT 0001104659-21-011853 7856
2021-02-03 4 OWNERSHIP DOCUMENT 0001104659-21-011852 7972
2021-02-03 4 OWNERSHIP DOCUMENT 0001104659-21-011851 7849
2021-02-03 4 OWNERSHIP DOCUMENT 0001104659-21-011850 7802
2021-02-03 4 OWNERSHIP DOCUMENT 0001104659-21-011849 5362
2021-02-03 4 OWNERSHIP DOCUMENT 0001104659-21-011848 5395
2021-02-03 4 OWNERSHIP DOCUMENT 0001104659-21-011847 5366
2021-02-03 4 OWNERSHIP DOCUMENT 0001104659-21-011846 5411
2021-02-03 4 OWNERSHIP DOCUMENT 0001104659-21-011845 5397
2021-02-03 4 OWNERSHIP DOCUMENT 0001104659-21-011844 5690
2021-02-03 3 OWNERSHIP DOCUMENT 0001104659-21-011843 13944
2021-02-01 8-K FORM 8-K 5.02,8.01,9.01 0001104659-21-009669 001-36672 21574296 34 205007
2021-01-21 D xslFormDX01/primary_doc.xml 06b 0001104659-21-006310 021-386998 21542156 33 11890
2021-01-12 SC 13D/A d8718740_13d-a.htm 0000919574-21-000243 005-88748 21524178 34 114988
2021-01-08 4 xslF345X03/ownership.xml 0000919574-21-000168 33543
2021-01-06 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001104659-21-001243 001-36672 21508975 34 422732
2021-01-05 4 OWNERSHIP DOCUMENT 0001104659-21-000935 5274
2021-01-05 4 OWNERSHIP DOCUMENT 0001104659-21-000934 5228
2021-01-05 4 OWNERSHIP DOCUMENT 0001104659-21-000932 5282
2021-01-05 4 OWNERSHIP DOCUMENT 0001104659-21-000927 4730
2021-01-04 D xslFormDX01/primary_doc.xml 06b 0001104659-20-141088 021-385028 201429750 33 12181
2020-12-21 8-K FORM 8-K 1.01,2.01,3.02,5.03,8.01,9.01 0001104659-20-137679 001-36672 201402355 34 591695
2020-12-08 4 OWNERSHIP DOCUMENT 0001104659-20-133326 4727
2020-12-08 4 OWNERSHIP DOCUMENT 0001104659-20-133325 5272
2020-12-08 4 OWNERSHIP DOCUMENT 0001104659-20-133324 4698

Latest XBRL company facts

One latest value per concept from companyfacts (435 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 4.42M 2026-11-10 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
dei EntityPublicFloat Entity Public Float USD 10.47M 2025-06-30 2025 FY 10-K 2026-03-25 0001372514-26-000024
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 720,346 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001372514-26-000040
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 737,118 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001372514-26-000040
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD -40 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001372514-26-000040
ffd NetFeeAmt NetFeeAmt USD 3,324.34 2026-04-06 S-3 2026-05-18 0001372514-26-000050
ffd TtlFeeAmt TtlFeeAmt USD 3,324.34 2026-04-06 S-3 2026-05-18 0001372514-26-000050
ffd TtlOfferingAmt TtlOfferingAmt USD 24.07M 2026-04-06 S-3 2026-05-18 0001372514-26-000050
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-06 S-3 2026-05-18 0001372514-26-000050
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 209,074 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 636,756 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 11,530 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 120,000 2022-07-31 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 223,162 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 25,912 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -245,606 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 175.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 17,726 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 1.66M 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD -1.25M 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 505,016 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 1.20M 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-07 0001372514-25-000078
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 2.93M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 211,740 2015-07-25 2015-09-01 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 18.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AreaOfLand Area of Land sqm 1,100 2022-02-01 2022 Q1 10-Q 2022-07-08 0001410578-22-001934
us-gaap Assets Assets USD 22.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AssetsCurrent Assets, Current USD 19.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 12.83M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AssetsNoncurrent Assets, Noncurrent USD 4.35M 2016-09-30 2016 Q3 10-Q 2016-11-01 0001144204-16-130888
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 63 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 20,937 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 10.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 1.31M 2024-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 1.31M 2024-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 10.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 10.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 10.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax USD -13.28M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -13.28M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 952,184 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 143,010 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 16.64M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap BusinessCombinationContingentConsiderationLiabilityMeasurementInput Business Combination, Contingent Consideration, Liability, Measurement Input pure 0.131 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 3.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContingentLiability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability USD 1.21M 2016-09-30 2016 Q3 10-Q 2016-11-01 0001144204-16-130888
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets USD 5,290 2021-10-21 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities USD 393,801 2016-09-30 2016 Q3 10-Q 2016-11-01 0001144204-16-130888
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities USD 265,808 2021-10-21 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill USD 1.06M 2021-10-21 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles USD 8.70M 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 300,000 2016-09-30 2016 Q3 10-Q 2016-11-01 0001144204-16-130888
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 1.17M 2021-10-21 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 649 2016-09-30 2016 Q3 10-Q 2016-11-01 0001144204-16-130888
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 1,572 2019-06-30 2019 Q2 10-Q 2019-08-08 0001144204-19-038393
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-02 0001144204-18-012542
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 0 2018-12-31 2018 FY 10-K 2019-03-01 0001144204-19-011634
us-gaap CapitalUnits Capital Units, Value USD 3.40M 2016-05-06 2017 Q2 10-Q 2017-08-04 0001144204-17-040582
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 50.00M 2019-05-13 2021 FY 10-K 2022-04-15 0001410578-22-000925
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-02 0001144204-18-012542
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 5.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 2.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -4.23M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-04 0001104659-20-029162
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5.58M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -3.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 8 2022-07-26 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 5.49M 2024-01-31 2026 Q1 10-Q 2026-05-08 0001372514-26-000047
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 1.28M 2023-08-07 2024 FY 10-K 2025-03-25 0001372514-25-000012
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 1.66M 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap CommonStockOtherSharesOutstanding Common Stock, Other Shares, Outstanding shares 545,000 2016-09-30 2016 Q3 10-Q 2016-11-01 0001144204-16-130888
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 4.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 4.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap CommonStockValue Common Stock, Value, Issued USD 281,915 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -13.34M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -6.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ContingentConsiderationClassifiedAsEquityFairValueDisclosure Contingent Consideration Classified as Equity, Fair Value Disclosure USD 3.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 2.69M 2018-12-31 2019 FY 10-K 2020-03-04 0001104659-20-029162
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 2.69M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001104659-21-041515
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001372514-26-000074
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 3.53M 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 1.36M 2018-04-17 2020 FY 10-K 2021-03-25 0001104659-21-041515
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 130,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001372514-23-000158
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 648,818 2019-09-30 2019 Q3 10-Q 2019-11-07 0001104659-19-060851
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -943,072 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD -14,784 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -893,612 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 64,244 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 4.2 2015-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 2.10M 2014-06-06 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.009 2012-10-01 2018 FY 10-K 2019-03-01 0001144204-19-011634
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 244,000 2015-02-13 2015 Q3 10-Q 2015-11-12 0001144204-15-064326
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 10.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 20,937 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions count 68 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064326
us-gaap DeferredCostsAndOtherAssets Deferred Costs and Other Assets USD 38,587 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 4,145 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD -388,537 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -294,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD -388,538 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 90,319 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 102,152 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap DeferredRevenue Deferred Revenue USD 2.69M 2018-12-31 2018 FY 10-K 2019-03-01 0001144204-19-011634
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 2.69M 2018-12-31 2019 Q2 10-Q 2019-08-08 0001144204-19-038393
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 4.00M 2017-02-01 2017-02-21 2017 Q1 10-Q 2017-05-05 0001144204-17-024841
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -98,682 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 17.28M 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.33M 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 413,139 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 14.20M 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 3,478 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 97,746 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits USD 0 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 265,856 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 377,639 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges USD 0 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 16.86M 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 102,152 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 453,253 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 269,968 2019-06-30 2019 Q2 10-Q 2019-08-08 0001144204-19-038393
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 62,038 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 29,200 2022-07-01 2022-09-30 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap Depreciation Depreciation USD 25,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 33,445 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 59.67M 2015-03-31 2015 Q1 10-Q 2015-05-18 0001144204-15-032063
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 8.22M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048608
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.72 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001104659-21-104182
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.105 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -3.492 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.027 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsExtraterritorialIncomeExclusion Effective Income Tax Rate Reconciliation, Deduction, Extraterritorial Income Exclusion, Percent pure 0.107 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.006 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure 0.214 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent pure 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001372514-25-000012
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.046 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001372514-25-000012
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 5,503 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-04 0001104659-20-029162
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 20,947 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity Embedded Derivative, No Longer Bifurcated, Amount Reclassified to Stockholders' Equity USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 853,145 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 500,000 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 700,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.5 2014-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap ExcessStockSharesAuthorized Excess Stock, Shares Authorized shares 59,414 2010-12-31 2024 Q1 10-Q 2024-05-10 0001372514-24-000053
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD -223,172 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 79,930 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 1,817 2020-12-31 2021 Q3 10-Q 2021-11-15 0001410578-21-000215
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 18,750 2022-12-31 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 25,000 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 18,750 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 25,000 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 25,000 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 25,000 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap FiniteLivedIntangibleAssetsFairValueDisclosure Finite-lived Intangible Assets, Fair Value Disclosure USD 2.10M 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 250,000 2020-12-31 2020 FY 10-K 2021-03-25 0001104659-21-041515
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -14,498 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-07-07 0001410578-22-001931
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap GainOrLossOnSaleOfStockInSubsidiary Gain (Loss) on Disposition of Stock in Subsidiary USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001372514-25-000012
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 4.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap Goodwill Goodwill USD 0 2022-12-31 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 1.77M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001410578-22-000925
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 4.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncomeLossBeforeExtraordinaryItemsAndCumulativeEffectOfChangeInAccountingPrinciple Income (Loss) from Operations before Extraordinary Items (Deprecated 2019-01-31) USD -6.27M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-10 0001144204-16-118057
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -7.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -6.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -4.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD 8.08M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001104659-21-041515
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 2.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 1.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 165,800 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 1.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncomeTaxReceivable Income Taxes Receivable USD 500,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -2.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 5,742 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 558,370 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -35,668 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 31,760 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 131,499 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -689,633 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -886,014 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -272,667 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD 689,928 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-04 0001104659-20-029162
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 1.25M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-07 0001372514-25-000078
us-gaap IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption Increase (Decrease) in Fair Value Adjustments on Other Assets (Liabilities) Carried at Fair Value under Fair Value Option USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 2.30M 2024-10-01 2024-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD 1.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap IncreaseDecreaseInLeaseAcquisitionCosts Increase (Decrease) in Lease Acquisition Costs AUD 25,000 2022-05-13 2022 Q1 10-Q 2022-07-08 0001410578-22-001934
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -129,695 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 23,383 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -219,829 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 19,257 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -342,029 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001144204-17-058607
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap IncreaseDecreaseInUnbilledReceivables Increase (Decrease) in Unbilled Receivables USD 689,928 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-03 0001144204-18-041798
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 604,784 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-06 0001104659-20-057438
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 852,500 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-06 0001104659-20-057438
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 2.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap InterestExpense Interest Expense USD 11,132 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 19,960 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 223,047 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-10 0001372514-24-000053
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 431,876 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-18 0001144204-15-032063
us-gaap InterestReceivable Interest Receivable USD 89,616 2016-09-30 2016 Q3 10-Q 2016-11-01 0001144204-16-130888
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 894,002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 10.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD -223,172 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064326
us-gaap LeaseCost Lease, Cost USD 188,100 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap LeaseIncentivePayableCurrent Lease Incentive, Payable, Current USD 31,576 2016-09-30 2016 Q3 10-Q 2016-11-01 0001144204-16-130888
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 301,331 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five USD 11,373 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four USD 10,728 2024-12-31 2024 FY 10-K 2025-03-25 0001372514-25-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three USD 85,636 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 136,716 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 173,129 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 155,908 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 11,528 2024-09-30 2024 Q3 10-Q 2024-11-08 0001372514-24-000120
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 85,636 2025-09-30 2025 Q3 10-Q 2025-11-07 0001372514-25-000078
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 89,921 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 55,502 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 14,542 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap Liabilities Liabilities USD 7.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 22.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-02 0001144204-18-012542
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.52M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 4.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 15,000 2016-06-01 2016-06-17 2018 Q1 10-Q 2018-05-11 0001144204-18-027296
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 278,190 2020-12-31 2021 FY 10-K/A 2022-07-07 0001410578-22-001931
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 1,987 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-08 0001372514-24-000120
us-gaap MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD 5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap MinorityInterestOwnershipPercentageByParent Noncontrolling Interest, Ownership Percentage by Parent pure 0.5 2015-02-13 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 4.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 10.62M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001144204-17-040582
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -2.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 0 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001144204-17-040582
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -5.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -2.50M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-04 0001144204-17-040582
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -6.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -0.93 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-02 0001144204-18-012542
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -10.39M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001144204-17-058607
us-gaap NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic USD -6.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted USD -6.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic USD 3.59M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001372514-25-000012
us-gaap NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted USD 3.59M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001372514-25-000012
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1 New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets (Deprecated 2020-01-31) USD 9.50M 2018-01-01 2019 FY 10-K 2020-03-04 0001104659-20-029162
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 333,836 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap NotesAssumed1 Notes Assumed USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap NotesPayableCurrent Notes Payable, Current USD 212,281 2020-12-31 2021 FY 10-K/A 2022-07-07 0001410578-22-001931
us-gaap NotesReceivableRelatedParties Notes Receivable, Related Parties USD 58,824 2016-09-30 2016 Q3 10-Q 2016-11-01 0001144204-16-130888
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OperatingExpenses Operating Expenses USD 7.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -6.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OperatingLeaseCost Operating Lease, Cost USD 120,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 286,789 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 162,095 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 124,694 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OperatingLeasePayments Operating Lease, Payments USD 123,249 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 219,565 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 12,500 2015-03-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.059 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 53.80M 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 73,321 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 84,351 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest USD -1,072 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-09 0001372514-25-000044
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -30,520 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 31,050 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 91,211 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 5,148 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -98,040 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 0 2025-03-31 2025 Q1 10-Q 2025-05-09 0001372514-25-000044
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 0 2017-12-31 2017 FY 10-K 2018-03-02 0001144204-18-012542
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001372514-25-000012
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 323,814 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap PaymentsForRoyalties Payments for Royalties USD 100,000 2012-01-01 2012-01-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001104659-21-041515
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 71,701 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 17,725 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 12.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap PaymentsToAcquireEquipmentOnLease Payments to Acquire Equipment on Lease USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-02 0001144204-18-012542
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 250,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-04 0001104659-20-029162
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 28,829 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap PreferredStockConversionsInducements Preferred Stock Conversions, Inducements USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2017-03-31 2017 Q1 10-Q 2017-05-05 0001144204-17-024841
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2017-03-31 2017 Q1 10-Q 2017-05-05 0001144204-17-024841
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 4 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.01M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 470,424 2024-09-30 2024 Q3 10-Q 2024-11-08 0001372514-24-000120
us-gaap PrepaidInsurance Prepaid Insurance USD 93,951 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ProceedsFromCollaborators Proceeds from Collaborators USD 16.00M 2024-01-01 2024-03-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-10 0001144204-16-118057
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-08 0001372514-24-000120
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 300,000 2020-05-01 2020-05-31 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 10.10M 2018-04-17 2020 FY 10-K 2021-03-25 0001104659-21-041515
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 9.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans Proceeds from Repayment of Loans by Employee Stock Ownership Plans USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001144204-19-011634
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-25 0001372514-24-000026
us-gaap ProceedsFromSalesOfAssetsInvestingActivities Proceeds from Sales of Assets, Investing Activities USD 6,375 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001144204-19-011634
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 170 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 11.09M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 117,584 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 88,192 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock Receivable from Shareholders or Affiliates for Issuance of Capital Stock USD 0 2017-12-31 2017 FY 10-K 2018-03-02 0001144204-18-012542
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 6.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 4,765 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -160.46M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2021-01-01 2021-12-31 2021 FY 10-K/A 2022-07-07 0001410578-22-001931
us-gaap RevenueNotFromContractWithCustomer Revenue Not from Contract with Customer USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap Revenues Revenues USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 50,742 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 5.60M 2023-06-06 2024 FY 10-K 2025-03-25 0001372514-25-000012
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 87,952 2016-05-24 2019 FY 10-K 2020-03-04 0001104659-20-029162
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 1.10M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001144204-18-027296
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 109,809 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0001372514-25-000061
us-gaap SeveranceCosts1 Severance Costs USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0001372514-23-000158
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 505,016 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 Share-based Payment Arrangement, Expensed and Capitalized, Amount USD 505,016 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 11,110 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 1.50M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 9.04 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064326
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 70,985 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 260 2021-01-01 2021-09-30 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.296 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.366 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.328 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.039 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 59,414 2010-12-31 2021 Q3 10-Q 2021-11-15 0001410578-21-000215
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 345,865 2021-12-31 2021 FY 10-K/A 2022-07-07 0001410578-22-001931
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 114,649 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 21.04 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-01 0001144204-19-011634
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 29,155 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 31,087 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 343,809 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.17 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 60,616 2015-07-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 701,721 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.14 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 69,200 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 293,685 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 8.76 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 69,200 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 418,154 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.18M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001410578-21-000215
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 12.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.4 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 1.81M 2015-09-30 2015 Q3 10-Q 2015-11-12 0001144204-15-064326
us-gaap SharePrice Share Price USD/shares 2.56 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 92.1 2021-08-11 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares USD 3.67M 2022-09-23 2022 Q3 10-Q 2022-11-09 0001410578-22-003035
us-gaap ShortTermInvestments Short-term Investments USD 10.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-07-08 0001410578-22-001934
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 15.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 8.94M 2018-12-31 2018 FY 10-K 2019-03-01 0001144204-19-011634
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.111 2024-06-06 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap StockIssued1 Stock Issued USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 158,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-02 0001144204-18-012542
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 273 2021-09-17 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares 891,222 2010-01-01 2010-12-31 2015 Q1 10-Q 2015-05-18 0001144204-15-032063
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 23,075 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048608
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 67,936 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-23 0001372514-23-000050
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-25 0001372514-25-000012
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 54,097 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-01 0001144204-19-011634
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 13.81M 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-07 0001372514-25-000078
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 10.00M 2015-01-01 2015-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 32,000 2019-04-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001144204-19-038393
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 490 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001104659-21-041515
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 40,718 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-01 0001144204-19-011634
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 116,280 2018-01-02 2018 FY 10-K 2019-03-01 0001144204-19-011634
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 34,000 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 3.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001372514-26-000024
us-gaap WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0001372514-25-000012
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 0 2015-12-31 2015 FY 10-K 2016-03-30 0001144204-16-091485
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 5.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 7.01M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001104659-21-104182
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 86,954 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 5.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001372514-26-000092
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-23 0001144204-17-010635

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →